ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHFOOD AND DRUG ADMINISTRATION

Developing PBPK-model based mechanistic IVIVC for PLGA implants

Active
Institution
University of Texas at Austin, TX
Principal investigator
Feng Zhang
Funding
$250K
Duration
2024–2027
Open portfolio

Moonbase score

Still being scored

Abstract

There is an immediate need to understand the critical formulation parameters that may affect product performance in vitro and in vivo, with a goal of developing IVIVCs for long-acting injectables. In this proposal, we will develop IVIVCs for a long-acting PLGA-based solid implant using a physiologically based pharmacokinetic (PBPK) modeling approach. PBPK modeling “provides a unique opportunity to understand how the physicochemical properties of drug molecules/polymer, implant specific properties, critical formulation attributes, and physiology, among other things, influence the in vivo release mechanisms of LAI drug products and their disposition characteristics. Successful execution of the project will entail (1) developing a bio-predictive in-vitro release testing method and determining how critical formulation and physicochemical properties impact the in-vitro release of PLGA-based buprenorphine implants; and (2) using a bottom-up PBPK approach to build IVIVCs that predict in-vivo PK profiles of PLGA-based buprenorphine implants from in-vitro data.

Research team

  • Ming HuPI
  • Sebastian PolakPI
  • Feng ZhangPI

LOADING MOONBASE SCORE

FOOD AND DRUG ADMINISTRATIONU01ZFD1-CDER-T(03)1formulationphysicochemicalimplantphysicochemical propertiesbuprenorphinein-vitrolong-actingimplants

Questions for University of Texas at Austin

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.